Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc.

NNASDAQ:KLRS
1.43
USD
-0.03
(-2.05%)
-1.84EPS
68.80MMarket Cap
Mar 23Next Earn

Kalaris Therapeutics, Inc. Documents

FY2023 · Annual report

Form 10-K · 198 pages

Read Kalaris Therapeutics, Inc.'s results firsthand

Preview the first 2 pages of this annual report
Create a free account to start reading

Full documents are included with Professional

Q4 FY2023 documents